Defence Therapeutics Inc (DTC.CX)
0.51
+0.01
(+2.00%)
CAD |
CNSX |
Aug 25, 16:00
Defence Therapeutics Debt to Equity Ratio : 0.2889 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2889 |
| December 31, 2025 | -1.215 |
| September 30, 2025 | -2.111 |
| June 30, 2025 | -1.198 |
| March 31, 2025 | -6.338 |
| December 31, 2024 | -0.3718 |
| September 30, 2024 | -0.4469 |
| June 30, 2024 | -0.4872 |
| March 31, 2024 | -0.6972 |
| December 31, 2023 | -0.6598 |
| September 30, 2023 | -3.710 |
| June 30, 2023 | 1.115 |
| Date | Value |
|---|---|
| March 31, 2023 | 1.234 |
| December 31, 2022 | -0.8194 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | |
| June 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Spectral Medical, Inc. | -0.3529 |
| Resverlogix Corp. | -0.8247 |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 0.1318 |
| Restart Life Sciences Corp. | 0.2294 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.446M |
| Total Liabilities (Quarterly) | 4.031M |
| Shareholders Equity (Quarterly) | 5.415M |
| Current Ratio | 3.367 |
| Net Debt Paydown Yield | -0.13% |